Aims and Scope
Journal of Brain and Spinal Cancer advances neuro-oncology through rigorous peer-reviewed research on CNS malignancies.
JBSC publishes research advancing understanding and treatment of central nervous system malignancies, from molecular mechanisms to clinical outcomes and patient care.
Glioblastoma and High-Grade Gliomas
Research on the most aggressive brain tumors including:
- Molecular subtypes and classification
- Treatment resistance mechanisms
- Novel therapeutic strategies
- Survival optimization approaches
Spinal Cord Tumors
Studies on intramedullary and extramedullary lesions:
- Surgical outcomes and techniques
- Functional preservation strategies
- Emerging treatment modalities
- Rehabilitation and recovery
Brain Metastases
Management of secondary CNS malignancies:
- Radiosurgery outcomes
- Immunotherapy approaches
- Prognostic factors
- Multimodal treatment strategies
Pediatric CNS Tumors
Research on childhood brain and spinal cancers:
- Medulloblastoma biology and treatment
- Ependymoma management
- Low-grade gliomas
- Neurocognitive outcomes
Molecular Neuro-Oncology
Translational and precision medicine research:
- Genomic profiling and biomarkers
- Targeted therapy development
- Immunogenomics
- Drug resistance mechanisms
Surgical Neuro-Oncology
Advances in operative management:
- Resection techniques
- Intraoperative imaging
- Awake craniotomy
- Functional mapping
Expanded Scope: We also welcome systemic therapy and supportive/palliative neuro-oncology studies, epidemiology/disparities research, and emerging biomarker approaches (including CSF/liquid biopsy and tumor microenvironment work) relevant to CNS tumors.
Radiation Oncology
Stereotactic radiosurgery, proton therapy, fractionation strategies, and radiation-induced effects.
Immunotherapy
Checkpoint inhibitors, CAR-T cells, vaccine approaches, and immune microenvironment studies.
Neuroimaging
Advanced MRI, PET imaging, treatment response assessment, and radiomics applications.
Quality of Life
Patient-reported outcomes, survivorship, neurocognitive assessment, and supportive care.
Original Research
Full-length investigations with novel findings (5,000-7,000 words)
Review Articles
Systematic or narrative reviews synthesizing knowledge (6,000-8,000 words)
Case Reports
Unusual presentations or novel treatments (2,000-3,000 words)
Technical Notes
Innovative surgical or imaging techniques (2,000-3,000 words)
JBSC maintains rigorous standards for neuro-oncology research:
- Clear clinical or translational hypothesis
- Appropriate study design and methodology
- Transparent reporting of outcomes and limitations
- Statistical rigor with appropriate sample sizes
- Ethical compliance and data availability
- Relevance to CNS cancer patient care or understanding
Submit Your Research
Share your brain and spinal cancer research with the global neuro-oncology community.
